Conclusions The results show that L T in rabbits was followed by an immediate and short-term increase in aqueous humour ET-l that might be caused by leakage from uveal tissue. This may be responsible for the release of prostaglandins causing the lOP increase and inflammatory complications of LT.
Prostaglandins and neural elements are both involved in the mediation of this response.
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The frequency-doubled (532 nrn) Accepted in revised form: adminstered laser lesions and prostanoid release was associated with an initial hypertensive response and disruption of the blood-aqueous barrier with plasma leakage. 4 Little is known about the role of endogenous ETs in different laser treatment modalities used to reduce lOP in glaucoma. To evaluate the potential impact of intraocular ET-l changes on lOP following Nd:YAG LT, we investigated the connections between LT, aqueous humour ET-l concentration and lOP. lOP was measured with a Tono-Pen tonometer (Mentor 0&0, Santa Barbara, CA) before treatment. Post-LT lOP measurements followed by aqueous humour aspiration were performed at 3 and 12 h and 1, 3 and 7 days after the treatment. Mean readings based on a series of five measurements with less than 5% spread were accepted.
One eye of each rabbit was subjected to a 360° L T with a 532 nm frequency-doubled green Nd:YAG laser (Oculight GL-IRIS Medical Instruments) via a Trokel F/3 Gonio laser lens (Ocular Instruments), spot size 75 ILm (68 ILm in target tissue with Trokel lens), duration 50 ms, power 800 mW, number of laser spots 100 in 360°.
Treatment was conducted with adjacent but not The anterior chamber aqueous humour was withdrawn from both the treated and untreated eyes of each rabbit (using a 26 gauge needle and a tuberculin syringe) at 3 and 12 h and 1, 3 and 7 days after the treatment. The central cornea was cannulated, and then the samples were immediately frozen and stored at -70°C until assay.
For the assay, we used an in-house radioimmunoassay utilising a polydonal antibody against ET-l (Peninsula Laboratories, Belmont, CA). ET-1 for the standards was purchased from Sigma-Aldrich (St Louis, MO). Samples and standards were incubated with antibody for 48 h at 4 0c. After the addition of approximately 100 000 cpm [1 2 5 11ET -1 (Amersham International, Little Chalfont, UK) per tube, samples were incubated for 24 h. The separation of bound and free ET-1 was carried out by using a goat anti-rabbit second antibody. Samples were assayed in duplicate. The lOP value was calculated for each group at each follow-up time on treated and untreated eyes, respectively. A paired t-test was used to compare lOP and ET-1 concentration changes between the corresponding treated and untreated eyes. A p value less than 0.05 was considered to be statistically significant.
Results
The concentrations of ET-1 in aqueous humour significantly increased in the treated eyes at 3 and 12 h and 1 day after the treatment compared with the contralateral control eyes. ET-1 concentrations at 3 and 7 days after LT, however, did not differ significantly from the corresponding contralateral control values ( Table 1) .
The difference in lOP change between treated and untreated eyes was statistically significant at each of the follow-up times .. In the LT group, at 3 and 12 h after the laser treatment lOP was significantly higher than the 
The mechanism of the lowering of lOP by ETs is unclear. However, Lepple-Wienhues et aZY showed that ET -1 caused contraction of the ciliary muscle strips of the bovine eye. Because tension on the ciliary muscle regulates aqueous outflow and accommodation, ET -1-induced contraction of the ciliary muscle should induce accommodation and increase aqueous outflow. It has been shown that ET -1 has concentration-dependent direct effects on the ciliary muscle and on the contractile elements of the trabecular tissue. Higher ET-l concentrations cause constriction, and lower ET -1 levels cause relaxation. These responses seem to have an important role in both the lOP elevation and decrease induced by ETs. Also, higher ET concentrations can cause arterial vasoconstriction leading to reduce aqueous humour production and an lOP decrease. In fact, when perfused into the anterior chamber of the anaesthetised monkey eye, ET-l significantly increased the outflow facility and affected accommodation as predicted.3 Thus effects of ETs on the ciliary muscle may lead to the modification of lOP.
Abdel-Latif and Zhang13 demonstrated that ET-l caused contraction of both iris sphincter and dilator muscles of the rabbit. Similarly, Lepple-Wienhues and colleagues1 2 showed that ET-l was a potent contracting agent for bovine trabecular meshwork, considering that a similar signal transduction pathway is likely to be present in human ciliary muscles and that contraction by ET-l was observed in bovine ciliary muscle stripsY ETs were reported to release arachidonic acid and prostaglandins by stimulating phospholipase A2 in cultured smooth muscle and endothelial cells.14 Abdel Latif et al. 15 observed the same phenomenon in rabbit iris sphincter smooth muscle. The finding that PGE2 concentration in the cell medium was increased by ET-l provides a further probable mechanism for the cyclic adenosine monophosphate (cAMP) effect of ET-l. ETs activated phospholipase C, calcium mobilisation, PGE2 and cAMP production in human ciliary muscle cells. All these actions apparently were mediated by the ETA receptor.16 PGE2 was the major prostanoid found and its concentration increased rapidly follOWing laser irradiation. Further, the magnitude of this increase was related to the number of laser lesions adminstered. Besides PGE2, other prostanoids were identified in the aqueous humour samples, including PGD2 and PGF2 a . 4 The laser-induced aqueous protein enhancement was closely related to the corresponding changes in aqueous PGE2 content. PGE 1 and PGE2 cause a breakdown of the blood-aqueous barrier and an increase in lOP. Increased formation of prostaglandins is thus a likely mode of action of the ETs in the rabbit. 17 Since the effects of ETs on the blood-aqueous barrier and lOP were abolished by indomethacin pretreatment,u,16 it seems that prostaglandins and other arachidonic acid metabolites are the mediators of the responses studied.
Two distinct endothelin receptor subtypes have been cloned and expressed. They are named ETA and ETB. The ETA receptor selectively interacts with ET-l, whereas the ET B receptor is not selective.18 Activation of ETA and ET B receptors has been shown to stimulate phospholipase C, increase turnover of phosphoinositides, and increase intracellular calcium concentration. These actions are thought to lead to ET-induced contraction in smooth muscles.14 Activation of calcium mobilisation by the ETA receptor and subsequent contraction of the muscles should increase aqueous outflow by traction on the scleral spur and thus lower lOP. It is predicted that an ETA receptor-selective agonist will be ocular hypotensive in humans and will mimic the outflow effect of ET -1 in the anaesthetised monkey eye. 16 Whether activation of the ET B receptor affects lOP in humans is not established. However, Hague et al. 19 reported that the ETB receptor selective agonist, sarafotoxin S6c, lowered lOP in rabbits, but with a clearly slower time of onset compared with ET-l. They suggested that the ETA receptor probably mediates the early phase, and that the ET B receptor plays a key role in the later phase of the ET effect. ET-l increased production of PGE2 and cAMP in a dose dependent manner. ET-l activation of cAMP formation apparently was mediated by the ET B receptor subtype?O All these ET actions could affect the contractility of the ciliary muscle and are potentially important in regulating IOp?l
In our model L T resulted in an extremely large and immediate elevation of aqueous humour ET-l concentration. No similar response was observed in the untreated eyes. These results suggest that the elevation of aqueous ET-l concentration was due to an increase in ET -1 release from the uveal tissue (iris pillars), probably caused by tissue damage. In the L T group lOP alteration was statistically significant at each of the follow-up times between eyes that underwent L T and untreated eyes. Compared with the pre-treatment value, lOP increased following LT. On the contrary, this increase was not seen in the untreated contralateral eyes of the same animals.
In our experiment the lOP increase following L T seemed to represent the impact of the increased ET-1 level on aqueous humour dynamics, since exogenous ET-1 administered intracamerally and intravitreally in the rabbit has been found to have a similar effect on lOP, lasting at least for 5 days?2,23 In our model the lOP at 12 h after LT was significantly higher than the corresponding value for the untreated eyes of the same animals.
It was found in the previous experimental studies that the ET-1 induced lOP change is biphasic.3,22-24 In the rabbit exogenous ET-1 administration was followed by an immediate lOP rise within the first hours. This lOP elevation disappeared in at most 4 h after ET-1 administration, and subsequently a prolonged lOP reduction was found?2,25 In our model lOP was significantly lower in the LT group after the first day. It is well known that L T frequently causes both an initial increase and a subsequent decrease in lOP in the early post-laser hours and days?6,27 Since human L T is In summary, our findings suggest that the significant elevation of aqueous humour ET-1 concentration after LT and the corresponding relative lOP increase during the first hours after laser treatment may provide a possible explanation for the mechanism of the early lOP changes frequently seen following L T in clinical practice. However, further studies are necessary to elucidate the connection between aqueous humour ET -1 concentration and lOP in the human eye, which is considerably different from that of the rabbit in anterior chamber angle anatomy, as well as in physiological response to inflammation.
